Archives

by in
Entry Author Date Location
Indel Therapeutics Aims High With New Class of Antibiotics to Fight Hospital Infections 03/30/09 Seattle
Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic 03/24/09 San Diego
EU Spurns Gilead’s Aztreonam 03/20/09 Seattle
Optimer Raises $32.9M in Stock Offering 03/05/09 San Diego
Novophage Forming to Combat Antibiotic Resistance with Engineered Viruses 03/05/09 Boston
Optimer To Seek EU Approval 03/02/09 San Diego
Oscient to Shed 32% of Workers 02/12/09 Boston
Mpex Pharma Lands $27.5M in Fourth Round 02/10/09 San Diego
Forma Forms Antibiotic-Discovery Partnership with Cubist 01/26/09 Boston
Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial 01/26/09 Boston
Optimer’s Second Drug, for Traveler’s Diarrhea, Follows Fast Behind Lead “C. Diff” Antibiotic 01/23/09 San Diego
Targanta Gets $42M Buyout Offer From NJ Drug Firm 01/13/09 Boston
Targanta Cuts 75 Percent of Staff 12/18/08 Boston
FDA Declines Approval of Targanta Antibiotic 12/09/08 Boston
Rib-X Reveals “Positive” Antibiotic Data 12/08/08 Boston
Optimer Sharpens Up Commercial Game Plan, After “C.Diff” Drug Success 12/05/08 San Diego
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
Optimer Shares Skyrocket, as Drug Halts Deadly Bacterial Infection in Trial 11/10/08 San Diego
Optimer, Developer of Drug For “C. Diff” Bacteria, Awaits Pivotal Results 10/23/08 San Diego
Trius Therapeutics Wins $28M Contract From NIH For Bioterror Antibiotics 10/22/08 San Diego
Trius Therapeutics, Developer of Antibiotic Against MRSA, Taking On Pfizer’s Zyvox 10/20/08 San Diego
Targanta Preps For FDA Advisory Panel on New Antibiotic 10/14/08 Boston
Rib-X Pharma, and Its Lead Antibiotic, Gear Up for Prime Time 10/02/08 Boston
Targanta Aims to “Simplifi” Treatment of Deadly Bugs With Single-Shot Antibiotic 09/22/08 Boston
Enanta Pharmaceuticals Starts Clinical Trial of Antibiotic for Drug Resistant Bacteria 09/15/08 Boston
Targanta Antibiotic Shown Effective in Less-Frequent Dose 09/02/08 Boston
Cubist Agrees to Promote AstraZeneca Antibiotic 07/02/08 Boston
TetraPhase Aims to Fill the Antibiotic Pipeline—and its Executive Office 10/05/07 Boston
Page 4 of 4 « previous page

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Automatic's App Puts Your Smartphone in Charge of Your Car

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.